They also found that, by amplifying the cGAS-STING signaling of tumor tissue and activating innate immunity, this nanosystem can also further activate CD8+ T cell infiltration even in a tumor with low immunogenicity for synergistic tumor therapy. The gene discussed is CD8A; the disease is neoplasm.